Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Decker

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Vaccine|July 15, 2019
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwPMichael D Decker, David P Greenberg, David R Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2013
Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not supported when data are stratified by agePhilippe André, David R Johnson, David P Greenberg, et al.
Human Vaccines & Immunotherapeutics|July 13, 2017
Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and olderDavid P Greenberg, Corwin A Robertson, H Keipp Talbot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak controlKathryn B Kirkland, Elizabeth A Talbot, Michael D Decker, et al.
Vaccine|March 26, 2018
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USAVitali Pool, Antigona Tomovici, David R Johnson, et al.
Vaccine|July 13, 2004
Systematic review of the effects of pertussis vaccines in childrenEric Desauziers, Luc Hessel, Michael D Decker, et al.
The Journal of Infectious Diseases|August 27, 2014
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccineMichael D Decker, Phillip Hosbach, David R Johnson, et al.
Vaccine|September 20, 2016
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccineCorwin A Robertson, David P Greenberg, James Hedrick, et al.
The Pediatric Infectious Disease Journal|July 10, 2010
Reactogenicity of tetanus, diphtheria, 5-component acellular pertussis vaccine administered as a sixth consecutive acellular pertussis vaccine dose to adolescentsJohannes G Liese, Nikolaus Rieber, Thomas Malzer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2015
Regarding Primary Care Patients Who Received Influenza Vaccine at Veteran Health Administration Medical CentersMichael D Decker, Carlos A DiazGranados, Ayman Chit, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Vaccine|July 15, 2019
Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwPMichael D Decker, David P Greenberg, David R Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2013
Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not supported when data are stratified by agePhilippe André, David R Johnson, David P Greenberg, et al.
Human Vaccines & Immunotherapeutics|July 13, 2017
Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and olderDavid P Greenberg, Corwin A Robertson, H Keipp Talbot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2009
Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak controlKathryn B Kirkland, Elizabeth A Talbot, Michael D Decker, et al.
Vaccine|March 26, 2018
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USAVitali Pool, Antigona Tomovici, David R Johnson, et al.
Vaccine|July 13, 2004
Systematic review of the effects of pertussis vaccines in childrenEric Desauziers, Luc Hessel, Michael D Decker, et al.
The Journal of Infectious Diseases|August 27, 2014
Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccineMichael D Decker, Phillip Hosbach, David R Johnson, et al.
Vaccine|September 20, 2016
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccineCorwin A Robertson, David P Greenberg, James Hedrick, et al.
The Pediatric Infectious Disease Journal|July 10, 2010
Reactogenicity of tetanus, diphtheria, 5-component acellular pertussis vaccine administered as a sixth consecutive acellular pertussis vaccine dose to adolescentsJohannes G Liese, Nikolaus Rieber, Thomas Malzer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2015
Regarding Primary Care Patients Who Received Influenza Vaccine at Veteran Health Administration Medical CentersMichael D Decker, Carlos A DiazGranados, Ayman Chit, et al.
Pageof 5